Alternatives to HRT elicit a warning
U.S. regulators said Thursday that they had issued warnings to companies that are promoting unproven “alternative” hormone therapies for women.
The government sent letters to about 50 firms and websites that market supplements and creams as alternatives to hormone replacement therapy, warning them against making baseless claims that the treatments can help with serious diseases such as cancer, heart disease and osteoporosis.
“It’s particularly troublesome when these claims provide false hope to patients with serious or life-threatening conditions,” said Margaret Glavin, the Food and Drug Administration’s associate commissioner for regulatory affairs.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
